According to Zhitong Finance App, Rongchang Biotech (09995.HK) announced that for the first three quarters of 2026, operating income was 6.764 billion yuan, up 293.28% year on year; net profit attributable to shareholders of listed companies was 5.273 billion yuan, loss of 551 million yuan for the same period last year; basic earnings per share were 9.41 yuan.

Zhitongcaijing · 3d ago
According to Zhitong Finance App, Rongchang Biotech (09995.HK) announced that for the first three quarters of 2026, operating income was 6.764 billion yuan, up 293.28% year on year; net profit attributable to shareholders of listed companies was 5.273 billion yuan, loss of 551 million yuan for the same period last year; basic earnings per share were 9.41 yuan.